Original paper
Local control and survival in spinal cord compression from lymphoma and myeloma

https://doi.org/10.1016/S0167-8140(96)01858-0Get rights and content

Abstract

Background: Between 1979 and 1989, 48 cases of extradural spinal cord and cauda equina compression in patients with lymphoma (24) and myeloma (24) received local radiation therapy for control of cord compression. Twenty five (52%) of the cases were treated by surgical decompression prior to irradiation. Thirty five (73%) of the cases received chemotherapy following the diagnosis of spinal cord compression. Post-treatment outcome was assessed at a minimum follow-up of 24 months to determine the significant clinical and treatment factors following irradiation.

Results: Seventeen (71%) of the lymphoma and 15 (63%) of the myeloma patients achieved local control, here defined as improvement to, or maintenance of ambulation with minimal or no assistance for 3 months from the start of radiotherapy. At a median follow-up of 30 (2–98) for the lymphoma and 10 (1–87) months for the myeloma patients, the results showed that survival following local radiation therapy for cord compression was independently influenced by the underlying disease type in favour of lymphoma compared to myeloma (P < 0.01). The median duration of local control and survival figures were 23 and 48 months for the lymphomas compared to 4.5 and 10 months for the myeloma cases. Survival was also independently influenced by preservation of sphincter function at initial presentation (P < 0.02) and the achievement of local control following treatment (P < 0.01).

Discussion: We conclude that while disease type independently impacts on outcome following treatment of spinal cord compression in lymphoma and myeloma, within both of these disease types the achievement of local control of spinal cord compression is an important management priority, for without local control survival may be adversely affected.

References (22)

  • M.J. Gardner et al.
  • Cited by (51)

    • Neurological complications of multiple myeloma

      2022, Neurological Complications of Systemic Cancer and Antineoplastic Therapy
    • A Score Predicting Posttreatment Ambulatory Status in Patients Irradiated for Metastatic Spinal Cord Compression

      2008, International Journal of Radiation Oncology Biology Physics
      Citation Excerpt :

      In the present series, better post-RT ambulatory status was significantly associated with favorable primary tumor type (myeloma/lymphoma, breast cancer, prostate cancer), a longer interval (>15 months) between tumor diagnosis and MSCC, absence of visceral metastases at the time of RT, better motor function before RT, and slower development of motor deficits before radiotherapy (>14 days). These findings are in accordance with our previous study and the data from the literature, in particular regarding the impact of the tumor type, of motor function before RT, and of the time of developing motor deficits before RT (6, 10–13). The negative prognostic impact of both a shorter interval between tumor diagnosis and MSCC and a faster development of motor deficits before RT reflect faster growth of more aggressive tumors.

    • Spinal cord compression

      2007, European Journal of Cancer, Supplement
    • Do Bladder Cancer Patients with Metastatic Spinal Cord Compression Benefit from Radiotherapy Alone?

      2007, Urology
      Citation Excerpt :

      Thus it is reasonable to consider each primary tumor as a separate group of MSCC patients. The radiosensitivity of transitional cell carcinoma is lower than the radiosensitivity of breast cancer and myeloma.3,11,12 Breast cancer patients, prostate cancer patients, and myeloma patients are reported to have a significantly better survival prognosis than lung cancer patients.2,13

    • Short-course radiotherapy is not optimal for spinal cord compression due to myeloma

      2006, International Journal of Radiation Oncology Biology Physics
    View all citing articles on Scopus
    View full text